Impaired Flow-Mediated Dilation Before, During, and after Preeclampsia: A Systematic Review and Meta-Analysis

Hypertension

Volumn 67, Issue 2, 2016, Pages 415-423

  Weissgerber, Tracey L ^a   Milic, Natasa M ^a,b   Milin Lazovic, Jelena S ^b   Garovic, Vesna D ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Cardiovascular disease; endothelium; flow mediated dilation; hypertension; preeclampsia; pregnancy

Indexed keywords

ARTICLE; CARDIOVASCULAR RISK; ENDOTHELIAL DYSFUNCTION; GESTATION PERIOD; HUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PREECLAMPSIA; PRIORITY JOURNAL; PUERPERIUM; VASODILATATION; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; FEMALE; META ANALYSIS; PHYSIOLOGY; PREGNANCY; VASCULAR ENDOTHELIUM;

BLOOD FLOW VELOCITY; BRACHIAL ARTERY; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; VASODILATION;

EID: 84954387808     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.115.06554     Document Type: Article

References (76)

1. Hauth JC, Ewell MG, Levine RJ, Esterlitz JR, Sibai B, Curet LB, Catalano PM, Morris CD. Pregnancy outcomes in healthy nulliparas who developed hypertension. Calcium for Preeclampsia Prevention Study Group. Obstet Gynecol. 2000;95:24-28.
2. Knuist M, Bonsel GJ, Zondervan HA, Treffers PE. Intensification of fetal and maternal surveillance in pregnant women with hypertensive disorders. Int J Gynaecol Obstet. 1998;61:127-133.
3. American College of Obstetricians and Gynecologist: Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122:1122-1131. doi: 10.1097/01.AOG.0000437382.03963.88.
4. Roberts JM, Lain KY. Recent Insights into the pathogenesis of preeclampsia. Placenta. 2002;23:359-372. doi: 10.1053/plac.2002.0819.
5. Ahmed R, Dunford J, Mehran R, Robson S, Kunadian V. Pre-eclampsia and future cardiovascular risk among women: a review. J Am Coll Cardiol. 2014;63:1815-1822. doi: 10.1016/j.jacc.2014.02.529.
6. Cockell AP, Poston L. Flow-mediated vasodilatation is enhanced in normal pregnancy but reduced in preeclampsia. Hypertension. 1997;30(2 pt 1):247-251.
7. Myatt L, Webster RP. Vascular biology of preeclampsia. J Thromb Haemost. 2009;7:375-384. doi: 10.1111/j.1538-7836.2008.03259.x.
8. Mosca L, Benjamin EJ, Berra K, et al; American Heart Association. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the American Heart Association. J Am Coll Cardiol. 2011;57:1404-1423. doi: 10.1016/j.jacc.2011.02.005.
9. Bushnell C, McCullough LD, Awad IA, et al; American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council for High Blood Pressure Research. Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45:1545-1588. doi: 10.1161/01.str.0000442009.06663.48.
10. Weissgerber TL. Flow-mediated dilation: can new approaches provide greater mechanistic insight into vascular dysfunction in preeclampsia and other diseases Curr Hypertens Rep. 2014;16:487. doi: 10.1007/s11906-014-0487-z.
11. Inaba Y, Chen JA, Bergmann SR. Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a metaanalysis. Int J Cardiovasc Imaging. 2010;26:631-640. doi: 10.1007/s10554-010-9616-1.
12. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
13. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008-2012.
14. Kontopantelis E, Reeves D. Metaeasy: a meta-analysis add-in for Microsoft excel. J Stat Software. 2009;30:1-25.
15. Kontopantelis E, Reeves D. Performance of statistical methods for meta-analysis when true study effects are non-normally distributed: A simulation study. Stat Methods Med Res. 2012;21:409-426. doi: 10.1177/0962280210392008.
16. Takase B, Goto T, Hamabe A, Uehata A, Kuroda K, Satomura K, Ohsuzu F, Kurita A. Flow-mediated dilation in brachial artery in the second half of pregnancy and prediction of pre-eclampsia. J Hum Hypertens. 2003;17:697-704. doi: 10.1038/sj.jhh.1001599.
17. Anastasakis E, Paraskevas KI, Papantoniou N, Daskalakis G, Mesogitis S, Mikhailidis DP, Antsaklis A. Association between abnormal uterine artery Doppler flow velocimetry, risk of preeclampsia, and indices of arterial structure and function: a pilot study. Angiology. 2008;59:493-499. doi: 10.1177/0003319708316008.
18. Casas FA, Avaca HA, Majul CR, Ledesma BL, Manuale OD, Ferrari GM. Flow mediated vasodilation in women at risk for preeclampsia. Circulation. 2008;118:E484-E484.
19. Garciá RG, Celedón J, Sierra-Laguado J, Alarcón MA, Luengas C, Silva F, Arenas-Mantilla M, López-Jaramillo P. Raised C-reactive protein and impaired flow-mediated vasodilation precede the development of preeclampsia. Am J Hypertens. 2007;20:98-103. doi: 10.1016/j. amjhyper.2006.06.001.
20. Bruckmann A, Seeliger C, Schleusner E, Schlembach D. The relationship between endothelial function in women with isolated preeclampsia, iugr and gestational hypertension. Ultraschall in der Medizin. 2013;34. doi: 10.1055/s-0033-1354836.
21. Clausen P, Ekbom P, Damm P, Feldt-Rasmussen U, Nielsen B, Mathiesen ER, Feldt-Rasmussen B. Signs of maternal vascular dysfunction precede preeclampsia in women with type 1 diabetes. J Diabetes Complications. 2007;21:288-293. doi: 10.1016/j.jdiacomp.2006.03.004.
22. Gurgel Alves JA, Brennecke SP, Da Silva Costa F. Brachial artery flowmediated dilatation as a predictor of pre-eclampsia in the first trimester of pregnancy. Pregnancy Hypertens. 2012;2:217-218. doi: 10.1016/j. preghy.2012.04.075.
23. Noori M, Donald AE, Angelakopoulou A, Hingorani AD, Williams DJ. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension. Circulation. 2010;122:478-487. doi: 10.1161/CIRCULATIONAHA.109.895458.
24. Tani C, Bruno RM, Strigini F, Carli L, Bernardini M, Talarico R, Baldini C, Ghiadoni L, Mosca M. Changes of flow mediated dilation in pregnant patients with systemic autoimmune diseases. Clin Exp Rheumatol. 2013;31:470.
25. Kamat R, Jain V, Bahl A. Serial estimation of flow mediated dilatation in women at risk of hypertensive disorders of pregnancy. Int J Cardiol. 2011;149:17-22. doi: 10.1016/j.ijcard.2009.11.034.
26. Savvidou MD, Hingorani AD, Tsikas D, Frölich JC, Vallance P, Nicolaides KH. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet. 2003;361:1511-1517. doi: 10.1016/S0140-6736(03)13177-7.
27. Hale SA, Badger GJ, McBride C, Magness R, Bernstein IM. Prepregnancy vascular dysfunction in women who subsequently develop hypertension during pregnancy. Pregnancy Hypertens. 2013;3:140-145. doi: 10.1016/j. preghy.2013.01.006.
28. Ferreira NCE, Barbosa MCA, De Rezende FJF, Gutierrez Perez L. Predictive value of flow-mediated dilation (fmd) in pre-eclampsia. J Perinatal Med Conference: 10th World Congress of Perinatal Medicine. 2011;20111108.
29. Brandaõ AH, Félix LR, Patrício Edo C, Leite HV, Cabral AC. Difference of endothelial function during pregnancies as a method to predict preeclampsia. Arch Gynecol Obstet. 2014;290:471-477. doi: 10.1007/s00404-014-3243-3.
30. Adali E, Kurdoglu M, Adali F, Cim N, Yildizhan R, Kolusari A. The relationship between brachial artery flow-mediated dilatation, high sensitivity C-reactive protein, and uterine artery doppler velocimetry in women with pre-eclampsia. J Clin Ultrasound. 2011;39:191-197. doi: 10.1002/jcu.20781.
31. Brodszki J, Länne T, Laurini R, Strevens H, Wide-Swensson D, Marsál K. Vascular mechanical properties and endothelial function in pre-eclampsia with special reference to bilateral uterine artery notch. Acta Obstet Gynecol Scand. 2008;87:154-162. doi: 10.1080/00016340701733646.
32. Hamad RR, Eriksson MJ, Berg E, Larsson A, Bremme K. Impaired endothelial function and elevated levels of pentraxin 3 in early-onset preeclampsia. Acta Obstet Gynecol Scand. 2012;91:50-56. doi: 10.1111/j.1600-0412.2011.01238.x.
33. Lopez Molina K, Valdivia-Silva JE, Gonzalez Altamirano JC. Levels of proteinuria and vascular damage in healthy pregnant, preeclamptic, and non-proteinuric hypertensive women, assessed by vascular ultrasonography. [Spanish] valores de proteinuria y dano vascular en gestantes sanas, preeclampticas y con hipertension no proteinurica, evaluados por ultrasonografia vascular. Progresos en Obstetricia y Ginecologia. 2009;52:4-13. doi: 10.1016/S0304-5013(09)70139-6.
34. Mori T, Watanabe K, Iwasaki A, Kimura C, Matsushita H, Shinohara K, Wakatsuki A. Differences in vascular reactivity between pregnant women with chronic hypertension and preeclampsia. Hypertens Res. 2014;37:145-150. doi: 10.1038/hr.2013.131.
35. Saarelainen H, Kärkkaïnen H, Valtonen P, Punnonen K, Laitinen T, Heiskanen N, Lyyra-Laitinen T, Vanninen E, Heinonen S. Flow-mediated vasodilation is not attenuated in hypertensive pregnancies despite biochemical signs of inflammation. ISRN Obstet Gynecol. 2012;2012:709464. doi: 10.5402/2012/709464.
36. Takata M, Nakatsuka M, Kudo T. Differential blood flow in uterine, ophthalmic, and brachial arteries of preeclamptic women. Obstet Gynecol. 2002;100(5 pt 1):931-939.
37. Torrado J, Farro I, Farro F, Bia D, Zócalo Y, Sosa C, Scasso S, Alonso J, Armentano RL. Carotid-radial pulse wave velocity as an alternative tool for the evaluation of endothelial function during pregnancy: potential role in identifying hypertensive disorders of pregnancy. Conf Proc IEEE Eng Med Biol Soc. 2012;2012:5603-5606. doi: 10.1109/EMBC.2012.6347264.
38. Tyldum EV, Backe B, Støylen A, Slørdahl SA. Maternal left ventricular and endothelial functions in preeclampsia. Acta Obstet Gynecol Scand. 2012;91:566-573. doi: 10.1111/j.1600-0412.2011.01282.x.
39. Watanabe K, Mori T, Iwasaki A, Kimura C, Matsushita H, Shinohara K, Wakatsuki A. Increased oxidant generation in the metabolism of hypoxanthine to uric acid and endothelial dysfunction in early-onset and late-onset preeclamptic women. J Matern Fetal Neonatal Med. 2012;25:2662-2666. doi: 10.3109/14767058.2012.705396.
40. Yamamoto T, Suzuki Y, Kojima K, Suzumori N, Suzuki T. The biological investigation of prostacyclin in preeclamptic women seen reduced endothelial function. Hypertens Pregnancy. 2010;29:484-491. doi: 10.3109/10641950903322873.
41. Yoshida A, Nakao S, Kobayashi M, Kobayashi H. Flow-mediated vasodilation and plasma fibronectin levels in preeclampsia. Hypertension. 2000;36:400-404.
42. Oliveira OP, Araujo Júnior E, Lima JW, Salustiano EM, Ruano R, Martins WP, Costa Fda S. Flow-mediated dilation of brachial artery and endothelial dysfunction in pregnant women with preeclampsia: a case control study. Minerva Ginecol. 2015;67:307-313.
43. Kuscu NK, Kurhan Z, Yildirim Y, Tavli T, Koyuncu F. Detection of endothelial dysfunction in preeclamptic patients by using color Doppler sonography. Arch Gynecol Obstet. 2003;268:113-116. doi: 10.1007/s00404-002-0351-2.
44. Allameh SZ, Tehrani HG, Hashemi SM, Nia RB, Hoseini F. Assessment of endothelium: dependent vasodilation with a non-invasive method in patients with preeclampsia compared to normotensive pregnant women. J Res Med Sci. 2014;19:175-177.
45. Brandaõ AHF, Barbosa AS, Lopes APBM, Leite HV, Cabral ACV. Dopplerfluxometria de artérias oftálmicas e avaliacąõ da funcąõ endotelial nas formas precoce e tardia da pré-eclâmpsia function in early and late preeclampsia. Radiologia Brasileira. 2012;45:20-23.
46. Mori T, Watanabe K, Iwasaki A, Kimura C, Wakatsuki A. 297-pos: Vascular reactivity and carotid artery intima media thickness (imt) in women with early and late-onset preeclampsia and chronic hypertension. Pregnancy Hypertens. 2015;5:147-147.
47. Paèz O, Alfie J, Gorosito M, Puleio P, de Maria M, Prieto N, Majul C. Parallel decrease in arterial distensibility and in endothelium-dependent dilatation in young women with a history of pre-eclampsia. Clin Exp Hypertens. 2009;31:544-552. doi: 10.3109/10641960902890176.
48. Germain AM, Romanik MC, Guerra I, Solari S, Reyes MS, Johnson RJ, Price K, Karumanchi SA, Valdés G. Endothelial dysfunction: a link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events Hypertension. 2007;49:90-95. doi: 10.1161/01.HYP.0000251522.18094. d4.
49. Goynumer G, Yucel N, Adali E, Tan T, Baskent E, Karadag C. Vascular risk in women with a history of severe preeclampsia. J Clin Ultrasound. 2013;41:145-150. doi: 10.1002/jcu.21962.
50. Yinon Y, Kingdom JC, Odutayo A, Moineddin R, Drewlo S, Lai V, Cherney DZ, Hladunewich MA. Vascular dysfunction in women with a history of preeclampsia and intrauterine growth restriction: insights into future vascular risk. Circulation. 2010;122:1846-1853. doi: 10.1161/CIRCULATIONAHA.110.948455.
51. Hamad RR, Eriksson MJ, Silveira A, Hamsten A, Bremme K. Decreased flow-mediated dilation is present 1 year after a pre-eclamptic pregnancy. J Hypertens. 2007;25:2301-2307. doi: 10.1097/HJH.0b013e3282ef5fc0.
52. Chambers JC, Fusi L, Malik IS, Haskard DO, De Swiet M, Kooner JS. Association of maternal endothelial dysfunction with preeclampsia. JAMA. 2001;285:1607-1612.
53. Baris N, Gol M, Goktay AY, Karas C, Altay C, Akdeniz B, Guneri S, Demir N. Comparison of endothelial functions with flow mediated dilatation in women with and without preeclampsia. Eur Heart J. 2005;26:246.
54. Andrade JAFM, Carvalho FHC, Mota RMS, Andrade GAM, Feitosa HN, Ibiapina FLP, Medeiros FdC. Assessment of endothelial function by flowmediated dilation of the brachial artery in adolescents with a history of preeclampsia or a normotensive pregnancy artéria braquial em adolescentes com história de pré-eclâmpsia ou de gestacąõ normotensa. Rev Bras Saúde Mater Infant. 2014;14:81-90. doi: 10.1590/S1519-38292014000100008.
55. Scholten RR, Thijssen DJ, Lotgering FK, Hopman MT, Spaanderman ME. Cardiovascular effects of aerobic exercise training in formerly preeclamptic women and healthy parous control subjects. Am J Obstet Gynecol. 2014;211:516.e1-516.e11. doi: 10.1016/j.ajog.2014.04.025.
56. Barry DR, Utzschneider KM, Tong J, Gaba K, Leotta DF, Brunzell JD, Easterling TR. Intraabdominal fat, insulin sensitivity, and cardiovascular risk factors in postpartum women with a history of preeclampsia. Am J Obstet Gynecol. 2015;213:104.e1-104.11. doi: 10.1016/j. ajog.2015.05.040.
57. Lazdam M, De La Horra A, Diesch J, Francis J, Kenworthy Y, Shore A, Redman C, Neubauer S, Kharbanda R, Alp N, Kelly B, Leeson P. Longterm cardiac and vascular phenotype of young women with pregnancies complicated by preeclampsia. Heart. 2012;98:A77-A78.
58. Östlund E, Al-Nashi M, Hamad RR, Larsson A, Eriksson M, Bremme K, Kahan T. Normalized endothelial function but sustained cardiovascular risk profile 11 years following a pregnancy complicated by preeclampsia. Hypertens Res. 2013;36:1081-1087. doi: 10.1038/hr.2013.81.
59. Sandvik MK, Leirgul E, Nygård O, Ueland PM, Berg A, Svarstad E, Vikse BE. Preeclampsia in healthy women and endothelial dysfunction 10 years later. Am J Obstet Gynecol. 2013;209:569e1-569e10. doi: 10.1016/j. ajog.2013.07.024.
60. Henriques AC, Carvalho FH, Feitosa HN, Macena RH, Mota RM, Alencar JC. Endothelial dysfunction after pregnancy-induced hypertension. Int J Gynaecol Obstet. 2014;124:230-234. doi: 10.1016/j.ijgo.2013.08.016.
61. Aykas F, Solak Y, Erden A, Bulut K, Dogan S, Sarli B, Acmaz G, Afsar B, Siriopol D, Covic A, Sharma S, Johnson RJ, Kanbay M. Persistence of cardiovascular risk factors in women with previous preeclampsia: a longterm follow-up study. J Investig Med. 2015;63:641-645. doi: 10.1097/JIM.0000000000000189.
62. Green DJ, Jones H, Thijssen D, Cable NT, Atkinson G. Flowmediated dilation and cardiovascular event prediction: does nitric oxide matter Hypertension. 2011;57:363-369. doi: 10.1161/HYPERTENSIONAHA.110.167015.
63. Shechter M, Issachar A, Marai I, Koren-Morag N, Freinark D, Shahar Y, Shechter A, Feinberg MS. Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease. Int J Cardiol. 2009;134:52-58. doi: 10.1016/j.ijcard.2008.01.021.
64. Shechter M, Marai I, Marai S, Sherer Y, Sela BA, Feinberg MS, Rubinstein A, Shoenfeld Y. The association of endothelial dysfunction and cardiovascular events in healthy subjects and patients with cardiovascular disease. Isr Med Assoc J. 2007;9:271-276.
65. Yeboah J, Crouse JR, Hsu FC, Burke GL, Herrington DM. Brachial flowmediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation. 2007;115:2390-2397. doi: 10.1161/CIRCULATIONAHA.106.678276.
66. Shivalkar B, Dhondt D, Goovaerts I, Van Gaal L, Bartunek J, Van Crombrugge P, Vrints C. Flow mediated dilatation and cardiac function in type 1 diabetes mellitus. Am J Cardiol. 2006;97:77-82. doi: 10.1016/j. amjcard.2005.07.111.
67. Mak A, Liu Y, Ho RC. Endothelium-dependent but not endotheliumindependent flow-mediated dilation is significantly reduced in patients with systemic lupus erythematosus without vascular events: a metaanalysis and metaregression. J Rheumatol. 2011;38:1296-1303. doi: 10.3899/jrheum.101182.
68. Witte DR, Westerink J, de Koning EJ, van der Graaf Y, Grobbee DE, Bots ML. Is the association between flow-mediated dilation and cardiovascular risk limited to low-risk populations J Am Coll Cardiol. 2005;45:1987-1993. doi: 10.1016/j.jacc.2005.02.073.
69. Ras RT, Streppel MT, Draijer R, Zock PL. Flow-mediated dilation and cardiovascular risk prediction: a systematic review with meta-analysis. Int J Cardiol. 2013;168:344-351. doi: 10.1016/j.ijcard.2012.09.047.
70. Myatt L, Redman CW, Staff AC, Hansson S, Wilson ML, Laivuori H, Poston L, Roberts JM; Global Pregnancy CoLaboratory. Strategy for standardization of preeclampsia research study design. Hypertension. 2014;63:1293-1301. doi: 10.1161/HYPERTENSIONAHA.113.02664.
71. Thijssen DH, Black MA, Pyke KE, Padilla J, Atkinson G, Harris RA, Parker B, Widlansky ME, Tschakovsky ME, Green DJ. Assessment of flow-mediated dilation in humans: a methodological and physiological guideline. Am J Physiol Heart Circ Physiol. 2011;300:H2-H12. doi: 10.1152/ajpheart.00471.2010.
72. Black MA, Cable NT, Thijssen DH, Green DJ. Importance of measuring the time course of flow-mediated dilatation in humans. Hypertension. 2008;51:203-210. doi: 10.1161/HYPERTENSIONAHA.107.101014.
73. Atkinson G, Batterham AM. Allometric scaling of diameter change in the original flow-mediated dilation protocol. Atherosclerosis. 2013;226:425-427. doi: 10.1016/j.atherosclerosis.2012.11.027.
74. Stoner L, Faulkner J, Sabatier MJ. Is allometric scaling really a panacea for flow-mediated dilation Commentary on paper by Atkinson and Batterham. Atherosclerosis. 2013;228:280-281. doi: 10.1016/j. atherosclerosis.2013.02.001.
75. Woodman RJ, Mangoni AA. Adjusting for brachial artery diameter in the analysis of flow-mediated dilatation: pitfalls of a landmark paper Atherosclerosis. 2013;228:277-279. doi: 10.1016/j. atherosclerosis.2013.01.005.
76. DeVan AE, Pierce GL, Brooks FA, Seals DR. The dependence of FMD% on baseline diameter: a problem solved by allometric scaling-no problem in this case. Clin Sci (Lond). 2013;125:55-56. doi: 10.1042/CS20130047.